American Journal of Cardiology
Volume 77, Issue 4 , Pages 232-236 , 1 February 1996

Usefulness of antioxidant vitamins in suspected acute myocardial infarction (the Indian experiment of infarct survival-3)

Received 17 July 1995 ,Accepted 5 October 1995.

References 

  1. Grech ED, Jackson M, Ramsdale DR. Reperfusion injury after acute myocardial infarction. Br Med J. 1995;310:477–478
  2. Guarnieri C, Ferrari R, Visiolo O, Calderera CM, Nayler WG. Effect of tocopherol on hypoxic perfused and oxygenated rabbit heart muscle. J Mol Cell Cardiol. 1978;10:893–906
  3. Bernier M, Hearse DJ, Manning AS. Reperfusion induced arrhythmias and oxygen derived free radicals. Circ Res. 1986;58:331–340
  4. Bell D, Sackson M, Nicoll JJ, Miller A, Dawes J, Muir AT. Inflammatory response, neutrophil activation and free radical production after acute myocardial infarction: effect of thrombolytic treatment. Br Heart J. 1990;63:82–87
  5. Wartanowicz M, Panczenoko-Kresowska K, Ziemlanski S, Kowalska M, Okolska G. The effect of alpha-tocopherol and ascorbic acid on the serum lipid peroxide level in elderly people. Ann Nutr Metab. 1984;28:186–191
  6. Riemersma RA, Wood DA, Macintyre CC, Elton RA, Gey RF, Oliver ML. Risk of angina pectoris and plasma concentrations of vitamin A, E, C and carotene. Lancet. 1991;337:1–5
  7. Street DA, Comstock GW, Salkeld RM, Schuep W, Klag M. A population based case control study of the association of serum antioxidants and myocardial infarction (abstr). Am J Epidemiol. 1991;134:719–720
  8. Gaziano JM, Manson JE, Ridker PM, Buring JE, Hennekens CH. Betacarotene therapy for chronic stable angina (abstr). Circulation. 1990;82(suppl III):III–201
  9. Stampfer MJ, Hanneken CH, Manson JE, Colditz GA, Rosner B, Willet WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med. 1993;328:1444–1449
  10. Rimm EB, Stampfer MJ, Ascherio A, Giovanucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary artery disease in men. N Engl J Med. 1993;328:1450–1456
  11. Ceremuzynski L. Hormonal and metabolic reactions evoked by acute myocardial infarction. Circ Res. 1981;48:765–776
  12. Hume R, Weyer E, Rowan T, Reid DS, Hillis WS. Leucocyte ascorbic acid levels after myocardial infarction. Br Heart J. 1972;34:238–243
  13. Ramirej J, Flowers NC. Leucocyte ascorbic acid and its relation to coronary artery disease in man. Am J Clin Nutr. 1980;33:2079–2087
  14. Singh RB, Niaz MA, Rastogi S, Sharma JP, Kumar R, Bishnoi I, et al. Plasma level of antioxidant vitamins and oxidative stress in patients with suspected acute myocardial infarction. Acta Cardiol. 1994;49:441–452
  15. World Health Organization . Myocardial infarction community registers. Copenhagen: World Health Organization; 1976;
  16. Brubacher G, Vuilleumier JP. Vitamin C. In:  Curtism HC,  Roth M editor. Clinical Biochemistry: Principles and Methods. vol. 2:Berlin: de Grugter; 1974;p. 989–997
  17. Vuilleumier JP, Keller HE, Gysel D, Hunziker F. Clinical chemical methods for the routine assessment of the vitamin status in human population. Part I. The fat soluble vitamins A, E and beta-carotene. Int J Vit Nutr Res. 1983;53:265–272
  18. Naito C, Kawamura M, Yamamoto Y. Lipid peroxides as the initiating factors in atherosclerosis. NY Acad Med Sci. 1993;676:27–45
  19. Singh RB, Niaz MA, Ahmad S, Begum R, Agarwal P. Effect of antioxidant rich foods on plasma ascorbic acid, cardiac enzyme and lipid peroxides levels in patients hospitalized with acute myocardial infarction. J Am Diet Assoc. 1995;95:775–780
  20. Beamish RE. Vitamin E—then and now. Heart Beat. 1993;2:6–9
  21. Axford-Gatley RA, Wilson GJ. Reduction of experimental myocardial infarct size by oral administration of alpha tocopherol. Cardiovasc Res. 1991;25:89–92
  22. Axford-Gatley RA, Wilson GJ. Myocardial infarct size reduction by single high dose or repeated low dose vitamin E supplementation in rabbits. Can J Cardiol. 1993;9:94–98
  23. Dzizinskii AA, Katiubin VP. Effects of antioxidants and membrane protectors on clinical course and hemodynamics of patients of myocardial infarct. Ross Med Zh. 1992;1:32–34
  24. Dzizinskii AA, Katiubin VP. Clinical course and necrotic area size in patients with myocardial infarct requiring combined treatment including antioxidants and membrane protecting agents. Kardiologia. 1991;31:56–58
  25. Klein HH, Pich S, Lindert S, Nelendahl K, Niedmgnn P, Kneuzer H. Combination treatment with vitamin E and C in experimental myocardial infarction in pigs. Am Heart J. 1989;118:667–673
  26. Heinonen OP, Albanes D. The effects of vitamin E and betacarotene on the incidence of lung cancers in male smokers. The Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group. N Engl J Med. 1994;330:1029–1035
  27. Singh RB, Niaz MA, Ghosh S, Agarwal P, Ahmad S, Beegum R, et al. Randomized controlled trial of antioxidant vitamins and cardioprotective diet on hyperlipidemia oxidative stress and development of atherosclerosis: The Diet and Antioxidant Trial on Atherosclerosis. Cardiovasc Drug Ther. 1995;9:763–771
  28. Herbaczynska-Gedro K. Supplementation with vitamins C and E suppresses leukocyte oxygen-free radical production in patients with myocardial infarction. Eur Heart J. 1995;16:1044–1049

PII: S0002-9149(97)89384-8

American Journal of Cardiology
Volume 77, Issue 4 , Pages 232-236 , 1 February 1996

Article Tools